331 related articles for article (PubMed ID: 24939964)
1. Utilization of baclofen in maintenance of alcohol abstinence in patients with alcohol dependence and alcoholic hepatitis with or without cirrhosis.
Yamini D; Lee SH; Avanesyan A; Walter M; Runyon B
Alcohol Alcohol; 2014; 49(4):453-6. PubMed ID: 24939964
[TBL] [Abstract][Full Text] [Related]
2. Baclofen promotes alcohol abstinence in alcohol dependent cirrhotic patients with hepatitis C virus (HCV) infection.
Leggio L; Ferrulli A; Zambon A; Caputo F; Kenna GA; Swift RM; Addolorato G
Addict Behav; 2012 Apr; 37(4):561-4. PubMed ID: 22244707
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and biobehavioural basis of baclofen in the treatment of alcoholic liver disease (BacALD): study protocol for a randomised controlled trial.
Morley KC; Leung S; Baillie A; Haber PS
Contemp Clin Trials; 2013 Nov; 36(2):348-55. PubMed ID: 23939511
[TBL] [Abstract][Full Text] [Related]
4. One year of baclofen in 100 patients with or without cirrhosis: a French real-life experience.
Barrault C; Lison H; Roudot-Thoraval F; Garioud A; Costentin C; Béhar V; Medmoun M; Pulwermacher G; Hagège H; Cadranel JF
Eur J Gastroenterol Hepatol; 2017 Oct; 29(10):1155-1160. PubMed ID: 28727631
[TBL] [Abstract][Full Text] [Related]
5. A prospective cohort study examining the effectiveness of baclofen in the maintenance of abstinence in alcohol use disorder patients attending a joint liver and alcohol treatment clinic.
Owens L; Thompson A; Rose A; Gilmore I; Pirmohamed M; Richardson P
Alcohol; 2017 Aug; 62():11-15. PubMed ID: 28755747
[TBL] [Abstract][Full Text] [Related]
6. The presence of hepatitis B core antibody is associated with more advanced liver disease in alcoholic patients with cirrhosis.
Zhang M; Wu R; Jiang J; Minuk GY; Niu J
Alcohol; 2013 Nov; 47(7):553-8. PubMed ID: 24041840
[TBL] [Abstract][Full Text] [Related]
7. The safety and efficacy of baclofen to reduce alcohol use in veterans with chronic hepatitis C: a randomized controlled trial.
Hauser P; Fuller B; Ho SB; Thuras P; Kern S; Dieperink E
Addiction; 2017 Jul; 112(7):1173-1183. PubMed ID: 28192622
[TBL] [Abstract][Full Text] [Related]
8. Baclofen and severe alcohol dependence: an uncertain harm-benefit balance as of early 2013.
Prescrire Int; 2013 Sep; 22(141):214-7. PubMed ID: 24171218
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study.
Addolorato G; Leggio L; Ferrulli A; Cardone S; Vonghia L; Mirijello A; Abenavoli L; D'Angelo C; Caputo F; Zambon A; Haber PS; Gasbarrini G
Lancet; 2007 Dec; 370(9603):1915-22. PubMed ID: 18068515
[TBL] [Abstract][Full Text] [Related]
10. High-dose baclofen for treatment-resistant alcohol dependence.
Pastor A; Jones DM; Currie J
J Clin Psychopharmacol; 2012 Apr; 32(2):266-8. PubMed ID: 22367662
[TBL] [Abstract][Full Text] [Related]
11. Is baclofen a revolutionary medication in alcohol addiction management? Review and recent updates.
Gorsane MA; Kebir O; Hache G; Blecha L; Aubin HJ; Reynaud M; Benyamina A
Subst Abus; 2012; 33(4):336-49. PubMed ID: 22989277
[TBL] [Abstract][Full Text] [Related]
12. Normal or near normal aminotransferase levels in patients with alcoholic cirrhosis.
Sullivan MK; Daher HB; Rockey DC
Am J Med Sci; 2022 Jun; 363(6):484-489. PubMed ID: 34619146
[TBL] [Abstract][Full Text] [Related]
13. Clinical experience with baclofen in the management of alcohol-dependent patients with psychiatric comorbidity: a selected case series.
Dore GM; Lo K; Juckes L; Bezyan S; Latt N
Alcohol Alcohol; 2011; 46(6):714-20. PubMed ID: 21890485
[TBL] [Abstract][Full Text] [Related]
14. Effects of intermittent Pringle's manoeuvre on cirrhotic compared with normal liver.
Sugiyama Y; Ishizaki Y; Imamura H; Sugo H; Yoshimoto J; Kawasaki S
Br J Surg; 2010 Jul; 97(7):1062-9. PubMed ID: 20632273
[TBL] [Abstract][Full Text] [Related]
15. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.
Giannini E; Botta F; Testa E; Romagnoli P; Polegato S; Malfatti F; Fumagalli A; Chiarbonello B; Risso D; Testa R
Am J Gastroenterol; 2002 Nov; 97(11):2855-60. PubMed ID: 12425560
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of baclofen on abstinence and craving in alcohol-dependent patients: a meta-analysis of randomized controlled trials.
Lesouef N; Bellet F; Mounier G; Beyens MN
Therapie; 2014; 69(5):427-35. PubMed ID: 25230278
[TBL] [Abstract][Full Text] [Related]
17. Alanine aminotransferase/aspartate aminotransferase ratio reversal and prolonged prothrombin time: a specific indicator of hepatic cirrhosis.
Siddiqi AI; Siddiqeh M; Mehmood A; Siddiqui AM
J Ayub Med Coll Abbottabad; 2007; 19(3):22-4. PubMed ID: 18444585
[TBL] [Abstract][Full Text] [Related]
18. Baclofen as add-on to standard psychosocial treatment for alcohol dependence: a randomized, double-blind, placebo-controlled trial with 1 year follow-up.
Ponizovsky AM; Rosca P; Aronovich E; Weizman A; Grinshpoon A
J Subst Abuse Treat; 2015 May; 52():24-30. PubMed ID: 25572706
[TBL] [Abstract][Full Text] [Related]
19. A human laboratory pilot study with baclofen in alcoholic individuals.
Leggio L; Zywiak WH; McGeary JE; Edwards S; Fricchione SR; Shoaff JR; Addolorato G; Swift RM; Kenna GA
Pharmacol Biochem Behav; 2013 Feb; 103(4):784-91. PubMed ID: 23262301
[TBL] [Abstract][Full Text] [Related]
20. [Double blind placebo controlled randomized pilot clinical trial of baclofen (Baclosan®) for alcohol dependence].
Krupitsky EM; Rybakova KV; Kiselev AS; Alexeeva YV; Berntsev VA; Chekhlaty EI; Zubova EY; Popov YV; Neznanov NG
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(6):53-62. PubMed ID: 26356398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
